EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis
Xiaokun Liu, Xiao Gao, Yuling Yang, Di Yang, Qingming Guo, Lianhui Li, Shunlong Liu, Wanxin Cong, Sen Lu, Lin Hou, Bin Wang, Ning Li
Topics & Concepts
LenvatinibPI3K/AKT/mTOR pathwayProtein kinase BCancer researchDownregulation and upregulationSignal transductionGene silencingMdm2Cell growthApoptosisBiologySorafenibHepatocellular carcinomaCell biologyBiochemistryGenePancreatic and Hepatic Oncology ResearchAutophagy in Disease and TherapyEpigenetics and DNA Methylation